Insulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulators - Wikidata - wikimedia - TriplyDB

Insulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulators

Insulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulators

http://www.wikidata.org/entity/Q28081458

about

Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21 Effects of Lycium barbarum. polysaccharide on type 2 diabetes mellitus rats by regulating biological rhythms.Urinary chromium is associated with changes in leukocyte miRNA expression in obese subjects.Pro-angiogenic Role of Insulin: From Physiology to Pathology.Challenging of AS160/TBC1D4 Alters Intracellular Lipid milieu in L6 Myotubes Incubated With Palmitate.The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.Nutrient supply affects the mRNA expression profile of the porcine skeletal muscle.Hyposialylated IgG activates endothelial IgG receptor FcγRIIB to promote obesity-induced insulin resistance.Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.

P2860

Q36970160-93546A8F-02AE-45E9-9291-24C9B1D1D921 Q37366426-E2FEB697-34A7-4B3D-86E4-6CF63BD459FD Q37575317-2281CE82-8EBF-49E8-9AAE-1A49E4DAD72F Q37737606-026599A9-2E3D-4D2F-BBB2-2A4352C371C2 Q38742105-E3ADA9A2-2C7F-4FAE-8141-2B707AF8381E Q39018887-88AF6005-6402-4E48-ADC5-506F74F771B7 Q41363353-AB5F52A2-0B0F-4E90-8809-842DD458701E Q50088056-E243769C-340C-4404-85C6-90F165C45BC9 Q53787596-9B5BD8B1-8A65-444D-B180-0B5EBF0D813B

P2860

Insulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulators

http://www.wikidata.org/entity/Q28081458

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Insulin resistance and skeleta ...... ent and therapeutic modulators

@ast

Insulin resistance and skeleta ...... ent and therapeutic modulators

@en

Insulin resistance and skeleta ...... ent and therapeutic modulators

@nl

type

label

Insulin resistance and skeleta ...... ent and therapeutic modulators

@ast

Insulin resistance and skeleta ...... ent and therapeutic modulators

@en

Insulin resistance and skeleta ...... ent and therapeutic modulators

@nl

prefLabel

Insulin resistance and skeleta ...... ent and therapeutic modulators

@ast

Insulin resistance and skeleta ...... ent and therapeutic modulators

@en

Insulin resistance and skeleta ...... ent and therapeutic modulators

@nl

P1433

Q28081458-F64F703A-0DB2-443B-BB4D-5F12150A7D07

P1476

Q28081458-05BF0C85-8703-4BCE-957E-368F2B0B1F57

P2093

Q28081458-782D378A-F099-4D19-8BAC-60DF7C148CF6

Q28081458-83BD6F9C-786A-4A7A-A84E-EEE5BBF11761

P2860

Q28081458-065E3476-740C-4EA7-B0EA-DE48EF6F8E19

Q28081458-0958F699-3316-49CB-876A-3303F0DAB342

Q28081458-0ECC6A5C-54AA-402C-BBDC-6D781BEDED1A

Q28081458-0EFA3147-8F81-4677-A414-7C4A73289E27

Q28081458-11CF7D22-8101-44AD-AF71-51B0BD13C011

Q28081458-13AD3190-3BF4-42BE-A137-DFF23ED9B137

Q28081458-19F45A09-525C-4DCB-AE96-5E46B4BE8DED

Q28081458-1AC9103E-5E73-46F7-A31A-A81A688C33B3

Q28081458-1D6ABF33-51DE-4F9D-B01F-4D15A9922942

Q28081458-2104CEC1-34B5-459E-9CB0-FFBECFFA4665

P304

Q28081458-2D2CA43E-3A11-421C-A72D-81ABEA5A7316

P31

Q28081458-A066F2E6-8403-4984-ABAC-0E8876FCAD03

P3181

Q28081458-A4C3CCB6-9472-4D34-AAE1-2533150EDB78

P356

Q28081458-401BC8D0-9FB4-4B32-8269-CD4D1909728D

P407

Q28081458-4F44B470-61BE-4FAF-AA2A-F250AFCE92F4

P433

Q28081458-C48FDBFB-B8E2-42C6-805F-26DE5D691D15

P478

Q28081458-57264584-8CD7-41B7-994B-8BEF5E635BD4

P577

Q28081458-DDBFF77B-713E-4800-9A8C-EFAAA1FC4106

P698

Q28081458-BABFB9DD-B591-4057-A524-322D82AB6D74

P921

Q28081458-0AEF379E-3973-4079-972A-F8166D629DCC

P932

Q28081458-9BD994A3-C80F-4DA6-A1D0-94AD7DE8D7FD

P3181

P356

P1433

Cardiorenal medicine

P1476

Insulin resistance and skeleta ...... ent and therapeutic modulators

@en

P2093

Camila Manrique

http://www.w3.org/2001/XMLSchema#string

James R. Sowers

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients

Muscle perfusion: its measurement and role in metabolic regulation

Role for endothelial cell conduction in ascending vasodilatation and exercise hyperaemia in hamster skeletal muscle

Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act

Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin

G protein-coupled receptor kinase 2, with β-arrestin 2, impairs insulin-induced Akt/endothelial nitric oxide synthase signaling in ob/ob mouse aorta

Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment.

Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow.

Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin.

Nitric oxide directly promotes vascular endothelial insulin transport.

P304

244-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1416379

http://www.w3.org/2001/XMLSchema#string

P356

10.1159/000368423

http://www.w3.org/2001/XMLSchema#string

P407

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25737689

http://www.w3.org/2001/XMLSchema#string

P921

P932

4299173

http://www.w3.org/2001/XMLSchema#string